Avadel Pharmaceuticals PLC (AVDL) — Financial Flexibility Index
Avadel Pharmaceuticals PLC (AVDL) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of $23.27 Million (operating CF $23.26 Million minus capex $10.76K) represents 0% of total liabilities ($101.22 Million). Check Avadel Pharmaceuticals PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Avadel Pharmaceuticals PLC Financial Flexibility Index (1996–2024)
Historical Financial Flexibility Index trend for Avadel Pharmaceuticals PLC across 29 annual periods. For the full cash flow conversion analysis, see AVDL cash flow metrics.
Annual Financial Flexibility Index for Avadel Pharmaceuticals PLC (1996–2024)
Year-by-year free cash flow to debt coverage for Avadel Pharmaceuticals PLC. Explore Avadel Pharmaceuticals PLC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.52x | $-46.91 Million | $-46.91 Million | $90.39 Million | ▲ +68.9% |
| 2023 | -1.67x | $-128.51 Million | $-128.51 Million | $76.96 Million | ▼ -269.4% |
| 2022 | -0.45x | $-69.59 Million | $-70.30 Million | $153.93 Million | ▲ +1.1% |
| 2021 | -0.46x | $-77.28 Million | $-77.31 Million | $169.02 Million | ▼ -40.4% |
| 2020 | -0.33x | $-48.64 Million | $-48.73 Million | $149.37 Million | ▼ -53.6% |
| 2019 | -0.21x | $-38.30 Million | $-38.33 Million | $180.63 Million | ▲ +36.4% |
| 2018 | -0.33x | $-62.54 Million | $-82.72 Million | $187.52 Million | ▼ -179.4% |
| 2017 | 0.42x | $70.36 Million | $16.66 Million | $167.54 Million | ▲ +325.0% |
| 2016 | 0.10x | $20.10 Million | $18.90 Million | $203.41 Million | ▼ -83.1% |
| 2015 | 0.58x | $85.92 Million | $84.29 Million | $147.11 Million | ▲ +1081.0% |
| 2014 | -0.06x | $-8.89 Million | $-10.62 Million | $149.31 Million | ▲ +61.9% |
| 2013 | -0.16x | $-19.65 Million | $-20.68 Million | $125.76 Million | ▲ +38.6% |
| 2012 | -0.25x | $-22.07 Million | $-23.14 Million | $86.81 Million | ▼ -19.6% |
| 2011 | -0.21x | $-8.42 Million | $-10.32 Million | $39.61 Million | ▼ -338.3% |
| 2010 | -0.05x | $-1.86 Million | $-5.46 Million | $38.31 Million | ▼ -124.1% |
| 2009 | 0.20x | $9.96 Million | $8.20 Million | $49.43 Million | ▲ +319.1% |
| 2008 | -0.09x | $-3.98 Million | $-7.51 Million | $43.31 Million | ▲ +46.0% |
| 2007 | -0.17x | $-7.97 Million | $-19.24 Million | $46.77 Million | ▲ +69.6% |
| 2006 | -0.56x | $-23.43 Million | $-29.83 Million | $41.87 Million | ▼ -161.7% |
| 2005 | -0.21x | $-8.06 Million | $-19.39 Million | $37.70 Million | ▼ -163.7% |
| 2004 | 0.34x | $9.69 Million | $-4.15 Million | $28.85 Million | ▼ -21.6% |
| 2003 | 0.43x | $15.07 Million | $12.23 Million | $35.19 Million | ▼ -54.7% |
| 2002 | 0.95x | $10.21 Million | $8.77 Million | $10.79 Million | ▲ +726.4% |
| 2001 | -0.15x | $-1.61 Million | $-2.78 Million | $10.63 Million | ▲ +70.7% |
| 2000 | -0.52x | $-4.88 Million | $-5.62 Million | $9.48 Million | ▲ +15.4% |
| 1999 | -0.61x | $-3.57 Million | $-4.24 Million | $5.85 Million | ▲ +35.0% |
| 1998 | -0.94x | $-7.06 Million | $-8.19 Million | $7.53 Million | ▲ +7.6% |
| 1997 | -1.01x | $-7.30 Million | $-8.90 Million | $7.20 Million | ▼ -155.3% |
| 1996 | -0.40x | $-2.70 Million | $-4.20 Million | $6.80 Million | — |